SI-BONE Inc. (SIBN)
14.61
-0.35 (-2.34%)
At close: Mar 21, 2025, 3:59 PM
-2.34% (1D)
| Bid | 14.5 |
| Market Cap | 620.24M |
| Revenue (ttm) | 170.64M |
| Net Income (ttm) | -31.55M |
| EPS (ttm) | -0.75 |
| PE Ratio (ttm) | -19.48 |
| Forward PE | -26.51 |
| Analyst | Buy |
| Ask | 18.76 |
| Volume | 358,318 |
| Avg. Volume (20D) | 368,549 |
| Open | 14.87 |
| Previous Close | 14.96 |
| Day's Range | 14.58 - 14.94 |
| 52-Week Range | 11.70 - 19.16 |
| Beta | 1.17 |
About SIBN
SI-BONE, Inc., a medical device company, develops implantable devices used to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers iFuse, a minimally invasive surgical implant system to address sacroiliac joint dysfunction and degeneration, adult deformity, and pelvic ring traumatic fractures. The company also provides iFuse-3D, a titanium implant that combines the triangular cross-section...
Industry Medical - Devices
Sector Healthcare
IPO Date Oct 17, 2018
Employees 349
Stock Exchange NASDAQ
Ticker Symbol SIBN
Website https://si-bone.com
Analyst Forecast
According to 7 analyst ratings, the average rating for SIBN stock is "Buy." The 12-month stock price forecast is $25, which is an increase of 71.12% from the latest price.
Stock ForecastsNext Earnings Release
SI-BONE Inc. is scheduled to release its earnings on May 5, 2025,
during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
3 weeks ago
+5.55%
SI-BONE shares are trading higher after the compan...
Unlock content with
Pro Subscription
2 months ago
+18.29%
SI-BONE shares are trading higher after the company reported preliminary Q4 revenue results.
3 weeks ago · seekingalpha.com
SI-BONE, Inc. (SIBN) Q4 2024 Earnings Call TranscriptSI-BONE, Inc. (SIBN) Q4 2024 Earnings Call Transcript
